ARCHIVES

ODAC Recommends Taxol For Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 20 No. 01 | January 7, 1994

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Program “Strengthened” NIH, Report From Biomedical Research Panel Contends

April 16, 1976

Funding Opportunities.

March 15, 2002

Nexavar Improves PFS In HER-2 Negative Breast Cancer

May 27, 2011

Steven Woolf: Why CMS Should Not Cover LDCT

May 9, 2014

Clearinghouse Completes Review of Backlog, Funds What Caused It, Reports On Program Value

May 19, 1978

Year 2000 Objectives In Health On Track

June 25, 1999